Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : APPI - Advanced Plant Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: John Hanzl who wrote (596)	9/3/1998 2:01:00 PM
From: Nescom	Respond to of 1263

News Release Advanced Plant Pharmaceuticals, Inc. APPI Announces It has Received an Initial Purchase Order From Kemin Industries, Inc. tagged for: APPI retrieval keys: !business !healthcare !public+companies !wall+street biz business corporate fda market marketing new+york otc patent pharmaceuticals technology usa NEW YORK (Sept. 3) BUSINESS WIRE -Sept. 3, 1998--ADVANCED PLANT PHARMACEUTICALS, INC. (OTC Bulletin Board APPI) announced today that it has received an initial purchase order from Kemin Industries, Inc. for the manufacture of pharmaceutical grade Rosemary pursuant to the Company's patent pending processing technologies. Pursuant to this initial order from Kemin Industries, the Company will deliver a test batch of Rosemary to be manufactured in accordance with the Company's proprietary whole plant standardizing process. The Company believes that delivery of product meeting Kemin's specifications will lead to ongoing purchase orders for this product and possibly other product offerings made by the Company. Mr. David Lieberman the Company's president said: "We are experiencing greater interest and reception for the Company's unique proprietary standardizing process from a broader range of nutritional and pharmaceutical Companies." Kemin Industries, Inc. produces; Crop Stabilizers, Antioxidants, Deodorants, Enzymes, Flavors, Surfactants, Mold Inhibitors, and Pigments. APPI is a company that develops innovative plant formulations and technology for clinical application. The Company believes that it has the capability of upgrading any nutritional product currently on the market to pharmaceutical grade. APPI has met FDA nutritional specifications for the marketing of its Lo-Chol in the USA. -0- rg/ny* sm CONTACT: Advanced Plant Pharmaceuticals, Inc. Martin Clare 212 402-7878

To: John Hanzl who wrote (596)	9/3/1998 3:09:00 PM
From: garyb	Read Replies (2) \| Respond to of 1263

John, I just talked to the company and was told 48 million outstanding shares. Don't know what's in float. Also told they are working on getting a new PR agency. I don't see any appreciation for this stock until Lochol starts shipping in volume. I can't believe they aren't selling massive quantities yet!! We'll just have to wait for more meaningful Press Releases. The new one regarding Kemin Industries is based on "new possibilities" You know, we've been getting these for about 2 years now. People are starting to wonder is there really any products this company actually produce? Cheers Garyb